{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2004"],"condition":["advanced/recurrent colorectal cancer"],"disease":["Advanced/recurrent Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2617107"],"location":["Japan"],"study_start_month":["2"],"repository":["ECRIN MDR"],"study_status":["Active, not recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A multicenter phase I/II study of irinotecan (CPT-11) and S-1 combination chemotherapy for metastatic colorectal cancer (CRC)","description":"Interventions: Irinotecan+S-1, repeated every 3 weeks.\nPrimary outcome(s): Phase I : recommended dose Phase I I: Response rate\nStudy Design: Single arm Non-randomized","dates":{"creation":"2004-02-15"},"accession":"2617107","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000001617"]}}